Clinical efficacy of a novel, high-sensitivity HBcrAg assay in the management of chronic hepatitis B and HBV reactivationTakako Inoue, Yasuhito Tanaka, Shigeru Kusumoto et al.|Journal of Hepatology|2021Cited by 110
Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysisHidenori Toyoda, Yasuhito Tanaka, Koichi Takaguchi et al.|Journal of Gastroenterology|2016Cited by 76
Erratum to: Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysisHidenori Toyoda, Yasuhito Tanaka, Etsuko Iio et al.|Journal of Gastroenterology|2016Cited by 60